Saffron improves life and sleep quality, glycaemic status, lipid profile and liver function in diabetic patients: A double‐blind, placebo‐controlled, randomised clinical trial

Abstract

Background: Type 2 diabetes (T2D) is a metabolic disorder that is related to hyperglycaemia, hyperlipidaemia and liver dysfunction and has detrimental effects on a patient's mental health. Hence, the current study investigated the effects of saffron supplementation on dietary intake, anthropometric measures, mood, sleep quality and metabolic biomarkers in overweight/obese patients with T2D.Methods: In a double-blind, randomised controlled trial, 70 overweight/obese patients with T2D were randomly allocated to two groups and received 100 mg/day saffron or placebo for 8 weeks. Participants completed the Beck depression inventory-II (BDI-II), Hurlbert index of sexual desire (HISD), Pittsburgh Sleep Quality Index (PSQI) and Diabetes-specific Quality-of-Life Brief Clinical Inventory questionnaires (DQOL-BCI). Dietary intake, anthropometric measures, fasting plasma glucose (FPG), haemoglobin A1C (HbA1C), insulin, lipid profile and liver enzymes were determined at baseline and the end of the study.Results: At the end of the eighth week, saffron supplementation significantly decreased FPG, triglyceride (TG), insulin, aspartate aminotransferase (AST) and alanine aminotransferase (ALT) (P < .001). Moreover, significant improvements in BDI-II scores and total quality of life were observed in the intervention group (P < .001).The saffron group showed more significant improvements in PSQI scores than the placebo group, such that at the post-intervention analysis, only the saffron group achieved a "good" sleep band. At this relatively high dose, saffron supplementation improved glycaemic status, lipid profile and liver enzyme measures in patients with T2D while also improving sleep and overall quality of life. Conclusion:Our results indicate that saffron notably reduced hyperglycaemia and hyperlipidaemia and improved liver function in patients with T2D in an 8-week randomised clinical trial. Saffron also significantly improved depression, sleep quality and overall quality of life in diabetic patients. However, further investigation is necessary to confirm whether saffron is an effective complementary therapy for T2D. How to cite this article: Tajaddini A, Roshanravan N, Mobasseri M, et al. Saffron improves life and sleep quality, glycaemic status, lipid profile and liver function in diabetic patients: A double-blind, placebo-controlled, randomised clinical trial. Int J

Crocus Sativus for Insomnia: A Systematic Review and Meta-Analysis

“…We included 8 studies with 431 participants [ 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 ] ( Table 1 ). One study was reported in two reports (Lopresti et al, 2020; Lopresti et al, 2021) and was referred to as Lopresti et al, (2021).…”

The cardiovascular‐protective properties of saffron and its potential pharmaceutical applications: A critical appraisal of the literature

“…Current, anti‐diabetic therapeutic approaches have targeted both optimal glycemic control and reduced cardiovascular risk (Siasos et al, 2020). Contrary to a plethora of animal studies, robust evidence supporting the hypoglycemic effects of saffron is lacking in humans, since this is documented only in a few randomized clinical studies (Milajerdi et al, 2018; Aleali et al, 2019; Tajaddini et al, 2021). Recently, a meta‐analysis enrolled nine randomized trials assessing the hypoglycemic effects of saffron or crocin (Rahmani et al, 2020).…”

An examination into the mental and physical effects of a saffron extract (affron®) in recreationally-active adults: A randomized, double-blind, placebo-controlled study

“…Based on a meta-analysis of 23 trials, it was demonstrated that saffron at a dose of 28 to 30 mg daily had positive effects on anxiety and depressive symptoms in adults with major depressive disorder and adults experiencing depressive symptoms [ 4 ]. At similar doses, saffron has also been shown to have mood-enhancing effects in peri-menopausal women [ 5 ], youth experiencing depressive and anxiety symptoms [ 6 ], adults with diabetes [ 7 ], and adults with metabolic syndrome [ 8 ]. It also has demonstrated positive effects on sleep quality in adults experiencing poor sleep [ 9 , 10 ].…”